Maintenance Pharmacological Treatment of Juvenile Bipolar Disorder: Review and Meta-Analyses.

Int J Neuropsychopharmacol · 2019 · PMC6672626 · PMID 31211354

Europe PMC DOI

hedged sentence

0.0200

closest p · 0.4× alpha

0.0200

boldest claim

The sentences

moderately significantP = .02actually significant

For nonrecurrence of new illness episodes, the pooled rate with drugs (56.7% [49.6–63.7]) was 13.3% superior to placebo (43.4% [34.7–52.4])—a moderately significant difference (χ 2 = 5.57, P = .02; Table 2 ).

also in 2,182 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.